Biophytis SA (BPTSY)
7.62
0.00 (0.00%)
USD |
OTCM |
May 28, 16:00
Biophytis Cash and Short Term Investments (Quarterly): 6.560M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.560M |
| June 30, 2023 | 6.753M |
| June 30, 2023 | 6.753M |
| December 31, 2022 | 12.49M |
| June 30, 2022 | 21.05M |
| June 30, 2022 | 21.05M |
| December 31, 2021 | 28.11M |
| June 30, 2021 | 27.86M |
| June 30, 2021 | 27.86M |
| December 31, 2020 | 23.09M |
| June 30, 2020 | 13.99M |
| Date | Value |
|---|---|
| June 30, 2019 | 5.920M |
| March 31, 2019 | 12.52M |
| June 30, 2018 | 16.33M |
| June 30, 2018 | 16.33M |
| December 31, 2017 | 23.82M |
| June 30, 2017 | 5.017M |
| June 30, 2017 | 5.017M |
| December 31, 2016 | 3.241M |
| June 30, 2016 | 7.570M |
| June 30, 2016 | 7.570M |
| December 31, 2015 | 10.29M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.920M
Minimum
Jun 2019
28.11M
Maximum
Dec 2021
16.79M
Average
17.52M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| DBV Technologies SA | 101.52M |
| Cellectis SA | 203.82M |
| Edap TMS SA | 41.51M |
| Genfit SA | 85.99M |
| Adaptimmune Therapeutics PLC | 143.65M |